These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 31807021)
1. Downregulation Of microRNA-133b And Its Clinical Value In Non-Small Cell Lung Cancer. Chen GY; Ruan L Onco Targets Ther; 2019; 12():9421-9434. PubMed ID: 31807021 [TBL] [Abstract][Full Text] [Related]
2. Down-regulation of microRNA-144-3p and its clinical value in non-small cell lung cancer: a comprehensive analysis based on microarray, miRNA-sequencing, and quantitative real-time PCR data. Chen YJ; Guo YN; Shi K; Huang HM; Huang SP; Xu WQ; Li ZY; Wei KL; Gan TQ; Chen G Respir Res; 2019 Mar; 20(1):48. PubMed ID: 30832674 [TBL] [Abstract][Full Text] [Related]
3. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer. Chen SW; Wang TB; Tian YH; Zheng YG Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832 [TBL] [Abstract][Full Text] [Related]
4. Identification of key microRNAs and hub genes in non-small-cell lung cancer using integrative bioinformatics and functional analyses. Song F; Xuan Z; Yang X; Ye X; Pan Z; Fang Q J Cell Biochem; 2020 Mar; 121(3):2690-2703. PubMed ID: 31692035 [TBL] [Abstract][Full Text] [Related]
5. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer. Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857 [TBL] [Abstract][Full Text] [Related]
6. Clinical value of microRNA-198-5p downregulation in lung adenocarcinoma and its potential pathways. Wang SS; Fang YY; Huang JC; Liang YY; Guo YN; Pan LJ; Chen G Oncol Lett; 2019 Sep; 18(3):2939-2954. PubMed ID: 31402959 [TBL] [Abstract][Full Text] [Related]
7. Expression Signature and Role of miR-30d-5p in Non-Small Cell Lung Cancer: a Comprehensive Study Based on in Silico Analysis of Public Databases and in Vitro Experiments. Gao L; He RQ; Wu HY; Zhang TT; Liang HW; Ye ZH; Li ZY; Xie TT; Shi Q; Ma J; Hu XH; Chen G Cell Physiol Biochem; 2018; 50(5):1964-1987. PubMed ID: 30396166 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of miR-145-5p in NSCLC and potential molecular mechanism exploration: A retrospective study based on GEO, qRT-PCR, and TCGA data. Gan TQ; Xie ZC; Tang RX; Zhang TT; Li DY; Li ZY; Chen G Tumour Biol; 2017 Mar; 39(3):1010428317691683. PubMed ID: 28347234 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value. Wu X; Huang J; Yang Z; Zhu Y; Zhang Y; Wang J; Yao W Cancer Cell Int; 2020; 20():443. PubMed ID: 32943991 [TBL] [Abstract][Full Text] [Related]
10. HuR, TTP, and miR-133b expression in NSCLC and their association with prognosis. Qian L; Ji AH; Zhang WJ; Zhao N Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):430-442. PubMed ID: 29424924 [TBL] [Abstract][Full Text] [Related]
11. Clinical value of miR-182-5p in lung squamous cell carcinoma: a study combining data from TCGA, GEO, and RT-qPCR validation. Luo J; Shi K; Yin SY; Tang RX; Chen WJ; Huang LZ; Gan TQ; Cai ZW; Chen G World J Surg Oncol; 2018 Apr; 16(1):76. PubMed ID: 29636077 [TBL] [Abstract][Full Text] [Related]
12. Role of miR-452-5p in the tumorigenesis of prostate cancer: A study based on the Cancer Genome Atl(TCGA), Gene Expression Omnibus (GEO), and bioinformatics analysis. Gao L; Zhang LJ; Li SH; Wei LL; Luo B; He RQ; Xia S Pathol Res Pract; 2018 May; 214(5):732-749. PubMed ID: 29559248 [TBL] [Abstract][Full Text] [Related]
13. Construction of a circular RNA-microRNA-messenger RNA regulatory network of hsa_circ_0043256 in lung cancer by integrated analysis. Li Y; Shi R; Zhu G; Chen C; Huang H; Gao M; Xu S; Cao P; Zhang Z; Wu D; Li X; Liu H; Chen J Thorac Cancer; 2022 Jan; 13(1):61-75. PubMed ID: 34806315 [TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of the predicted targets of miR-642b-3p associated with the long non-coding RNA HOXA11-AS in NSCLC cells. Zhang Y; Luo J; Wang X; Wang HL; Zhang XL; Gan TQ; Chen G; Luo DZ Oncol Lett; 2018 May; 15(5):6147-6160. PubMed ID: 29616096 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-133b inhibits the migration and invasion of non small cell lung cancer cells via targeting FSCN1. Yang X; Lei P; Huang Y; Zhang Z; Zhang Y Oncol Lett; 2016 Nov; 12(5):3619-3625. PubMed ID: 27900045 [TBL] [Abstract][Full Text] [Related]
17. Identification of key differentially expressed mRNAs and microRNAs in non-small cell lung cancer using bioinformatics analysis. Wang W; Wang S; Pan L Exp Ther Med; 2020 Oct; 20(4):3720-3732. PubMed ID: 32855723 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of hsa-microRNA-204-5p and identification of its potential regulatory network in non-small cell lung cancer: RT-qPCR, bioinformatic- and meta-analyses. Liang CY; Li ZY; Gan TQ; Fang YY; Gan BL; Chen WJ; Dang YW; Shi K; Feng ZB; Chen G Respir Res; 2020 Feb; 21(1):60. PubMed ID: 32102656 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma. Li J; Liu X; Cui Z; Han G Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582 [TBL] [Abstract][Full Text] [Related]
20. MiR-182-5p and its target HOXA9 in non-small cell lung cancer: a clinical and in-silico exploration with the combination of RT-qPCR, miRNA-seq and miRNA-chip. Gao L; Yan SB; Yang J; Kong JL; Shi K; Ma FC; Huang LZ; Luo J; Yin SY; He RQ; Hu XH; Chen G BMC Med Genomics; 2020 Jan; 13(1):3. PubMed ID: 31906958 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]